These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29065190)

  • 1. Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy.
    Shibata A; Kuno M; Adachi R; Sato Y; Hattori H; Matsuda A; Okuzono Y; Igaki K; Tominari Y; Takagi T; Yabuki M; Okaniwa M
    PLoS One; 2017; 12(10):e0186587. PubMed ID: 29065190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a novel prolyl-tRNA synthetase inhibitor and elucidation of its binding mode to the ATP site in complex with l-proline.
    Adachi R; Okada K; Skene R; Ogawa K; Miwa M; Tsuchinaga K; Ohkubo S; Henta T; Kawamoto T
    Biochem Biophys Res Commun; 2017 Jun; 488(2):393-399. PubMed ID: 28501621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamyl-Prolyl-tRNA Synthetase Regulates Proline-Rich Pro-Fibrotic Protein Synthesis During Cardiac Fibrosis.
    Wu J; Subbaiah KCV; Xie LH; Jiang F; Khor ES; Mickelsen D; Myers JR; Tang WHW; Yao P
    Circ Res; 2020 Aug; 127(6):827-846. PubMed ID: 32611237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational changes in human prolyl-tRNA synthetase upon binding of the substrates proline and ATP and the inhibitor halofuginone.
    Son J; Lee EH; Park M; Kim JH; Kim J; Kim S; Jeon YH; Hwang KY
    Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):2136-45. PubMed ID: 24100331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolyl-tRNA synthetase inhibition promotes cell death in SK-MEL-2 cells through GCN2-ATF4 pathway activation.
    Arita T; Morimoto M; Yamamoto Y; Miyashita H; Kitazawa S; Hirayama T; Sakamoto S; Miyamoto K; Adachi R; Iwatani M; Hara T
    Biochem Biophys Res Commun; 2017 Jul; 488(4):648-654. PubMed ID: 28087278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase.
    Keller TL; Zocco D; Sundrud MS; Hendrick M; Edenius M; Yum J; Kim YJ; Lee HK; Cortese JF; Wirth DF; Dignam JD; Rao A; Yeo CY; Mazitschek R; Whitman M
    Nat Chem Biol; 2012 Feb; 8(3):311-7. PubMed ID: 22327401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoacyl-tRNA synthetase inhibition activates a pathway that branches from the canonical amino acid response in mammalian cells.
    Kim Y; Sundrud MS; Zhou C; Edenius M; Zocco D; Powers K; Zhang M; Mazitschek R; Rao A; Yeo CY; Noss EH; Brenner MB; Whitman M; Keller TL
    Proc Natl Acad Sci U S A; 2020 Apr; 117(16):8900-8911. PubMed ID: 32253314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
    Yamamoto T; Nishioka K
    Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase.
    Zhou H; Sun L; Yang XL; Schimmel P
    Nature; 2013 Feb; 494(7435):121-4. PubMed ID: 23263184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Methoxyestradiol inhibits bleomycin-induced systemic sclerosis through suppression of fibroblast activation.
    Zhu L; Song Y; Li M
    J Dermatol Sci; 2015 Jan; 77(1):63-70. PubMed ID: 25465161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of Prolyl-tRNA Synthetase-Halofuginone Complex Provides Basis for Development of Drugs against Malaria and Toxoplasmosis.
    Jain V; Yogavel M; Oshima Y; Kikuchi H; Touquet B; Hakimi MA; Sharma A
    Structure; 2015 May; 23(5):819-829. PubMed ID: 25817387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid suppresses collagen by selective regulation of Smads in conjunctival fibrosis.
    Seet LF; Toh LZ; Finger SN; Chu SW; Stefanovic B; Wong TT
    J Mol Med (Berl); 2016 Mar; 94(3):321-34. PubMed ID: 26507880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards Novel 3-Aminopyrazinamide-Based Prolyl-tRNA Synthetase Inhibitors: In Silico Modelling, Thermal Shift Assay and Structural Studies.
    Pang L; Weeks SD; Juhás M; Strelkov SV; Zitko J; Van Aerschot A
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular TGF-beta receptor blockade abrogates Smad-dependent fibroblast activation in vitro and in vivo.
    Ishida W; Mori Y; Lakos G; Sun L; Shan F; Bowes S; Josiah S; Lee WC; Singh J; Ling LE; Varga J
    J Invest Dermatol; 2006 Aug; 126(8):1733-44. PubMed ID: 16741519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pin1 induction in the fibrotic liver and its roles in TGF-β1 expression and Smad2/3 phosphorylation.
    Yang JW; Hien TT; Lim SC; Jun DW; Choi HS; Yoon JH; Cho IJ; Kang KW
    J Hepatol; 2014 Jun; 60(6):1235-41. PubMed ID: 24530597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin.
    Hayashi S; Ikeda M; Kitamura Y; Hamasaki Y; Hatamochi A
    J Dermatol Sci; 2012 Jul; 67(1):20-5. PubMed ID: 22486844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
    J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosis.
    Santiago B; Gutierrez-Cañas I; Dotor J; Palao G; Lasarte JJ; Ruiz J; Prieto J; Borrás-Cuesta F; Pablos JL
    J Invest Dermatol; 2005 Sep; 125(3):450-5. PubMed ID: 16117784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.